290 related articles for article (PubMed ID: 32384725)
1. Primary Hemostasis in Chronic Liver Disease and Cirrhosis: What Did We Learn over the Past Decade?
van Dievoet MA; Eeckhoudt S; Stephenne X
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32384725
[TBL] [Abstract][Full Text] [Related]
2. Thrombopoietin Receptor Agonists in Patients with Chronic Liver Disease.
Khemichian S; Terrault NA
Semin Thromb Hemost; 2020 Sep; 46(6):682-692. PubMed ID: 32820479
[TBL] [Abstract][Full Text] [Related]
3. The hemostatic and thrombotic complications of liver disease.
McMurry HS; Jou J; Shatzel J
Eur J Haematol; 2021 Oct; 107(4):383-392. PubMed ID: 34258797
[TBL] [Abstract][Full Text] [Related]
4. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?
Violi F; Basili S; Raparelli V; Chowdary P; Gatt A; Burroughs AK
J Hepatol; 2011 Dec; 55(6):1415-27. PubMed ID: 21718668
[TBL] [Abstract][Full Text] [Related]
5. AGA Clinical Practice Update: Coagulation in Cirrhosis.
O'Leary JG; Greenberg CS; Patton HM; Caldwell SH
Gastroenterology; 2019 Jul; 157(1):34-43.e1. PubMed ID: 30986390
[TBL] [Abstract][Full Text] [Related]
6. Enhanced processing of von Willebrand factor reflects disease severity and discriminates severe portal hypertension in cirrhosis.
Langholm LL; Manon-Jensen T; Karsdal MA; Bendtsen F; Leeming DJ; Møller S
Eur J Gastroenterol Hepatol; 2019 Aug; 31(8):1040-1048. PubMed ID: 30768435
[TBL] [Abstract][Full Text] [Related]
7. The evolving knowledge on primary hemostasis in patients with cirrhosis: A comprehensive review.
Zanetto A; Campello E; Senzolo M; Simioni P
Hepatology; 2024 Feb; 79(2):460-481. PubMed ID: 36825598
[TBL] [Abstract][Full Text] [Related]
8. Factors associated with the platelet count in patients with chronic hepatitis C.
Tana MM; Zhao X; Bradshaw A; Moon MS; Page S; Turner T; Rivera E; Kleiner DE; Heller T
Thromb Res; 2015 May; 135(5):823-8. PubMed ID: 25728497
[TBL] [Abstract][Full Text] [Related]
9. Effects of increased von Willebrand factor levels on primary hemostasis in thrombocytopenic patients with liver cirrhosis.
Wannhoff A; Müller OJ; Friedrich K; Rupp C; Klöters-Plachky P; Leopold Y; Brune M; Senner M; Weiss KH; Stremmel W; Schemmer P; Katus HA; Gotthardt DN
PLoS One; 2014; 9(11):e112583. PubMed ID: 25397410
[TBL] [Abstract][Full Text] [Related]
10. Reticulated platelets as a marker of megakaryopoiesis in liver cirrhosis; relation to thrombopoietin and hepatocyte growth factor serum concentration.
Panasiuk A; Prokopowicz D; Zak J; Panasiuk B
Hepatogastroenterology; 2004; 51(58):1124-8. PubMed ID: 15239259
[TBL] [Abstract][Full Text] [Related]
11. Management of Thrombocytopenia in Patients with Chronic Liver Disease.
Saab S; Brown RS
Dig Dis Sci; 2019 Oct; 64(10):2757-2768. PubMed ID: 31011942
[TBL] [Abstract][Full Text] [Related]
12. Potential usefulness of thrombopoietin receptor agonists in haemophiliacs with thrombocytopaenia due to chronic liver disease.
Aguilar C
Blood Coagul Fibrinolysis; 2013 Apr; 24(3):231-6. PubMed ID: 23518832
[TBL] [Abstract][Full Text] [Related]
13. Role of the von Willebrand factor and the VITRO score as predictors for variceal bleeding in patients with hepatitis C-related cirrhosis.
Ibrahim EH; Marzouk SA; Zeid AE; Lashen SA; Taher TM
Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):241-247. PubMed ID: 30281535
[TBL] [Abstract][Full Text] [Related]
14. [Liver cirrhosis--procoagulant stasis].
Prelipcean CC; Fierbinteanu-Braticevici C; Drug VL; Lăcătuşu C; Mihai B; Mihai C
Rev Med Chir Soc Med Nat Iasi; 2011; 115(3):678-85. PubMed ID: 22046771
[TBL] [Abstract][Full Text] [Related]
15. Quantitative and qualitative analysis of platelet GPIb and von Willebrand factor in liver cirrhosis.
Beer JH; Clerici N; Baillod P; von Felten A; Schlappritzi E; Büchi L
Thromb Haemost; 1995 Apr; 73(4):601-9. PubMed ID: 7495066
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulation in cirrhosis: a new paradigm?
Leonardi F; Maria N; Villa E
Clin Mol Hepatol; 2017 Mar; 23(1):13-21. PubMed ID: 28288507
[TBL] [Abstract][Full Text] [Related]
17. Flow and delta-P dictate where thrombin, fibrin, and von Willebrand Factor will be found.
Diamond SL
Thromb Res; 2016 May; 141 Suppl 2():S22-4. PubMed ID: 27207416
[TBL] [Abstract][Full Text] [Related]
18. Infusion of DDAVP does not improve primary hemostasis in patients with cirrhosis.
Arshad F; Stoof SC; Leebeek FW; Ruitenbeek K; Adelmeijer J; Blokzijl H; van den Berg AP; Porte RJ; Kruip MJ; Lisman T
Liver Int; 2015 Jul; 35(7):1809-15. PubMed ID: 25522671
[TBL] [Abstract][Full Text] [Related]
19. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
[TBL] [Abstract][Full Text] [Related]
20. The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.
Rios R; Sangro B; Herrero I; Quiroga J; Prieto J
Am J Gastroenterol; 2005 Jun; 100(6):1311-6. PubMed ID: 15929762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
